In Brief This Week: Ventana; Paradigm; Thermo Fisher; Transgenomic; Atossa Genetics; SQI; 908 Devices | GenomeWeb

NEW YORK (GenomeWeb) – Roche's Ventana Medical Systems said that its Ventana System for Primary Diagnosis has received CE marking in the European Union for routine pathology, including primary diagnosis with human tissue specimens. The system comprises the Ventana Virtuoso software combined with either the Ventana iScan Coreo or the Ventana iScan HT slide scanner for the automated creation of digital slides, as well as automated case management and computer viewing of human tissue specimens. The iScan Coreo slide scanner is a brightfield 160-slide capacity scanner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions. is eyeing an expansion into genomic risk assessments, the Verge reports.